from FOX News https://ift.tt/3yf1Npm
CureVac COVID-19 vaccine hits just 48% efficacy in final analysis
German biotech company CureVac announced its COVID-19 vaccine demonstrated 48% efficacy against COVID-19 of any severity in a final readout of late-stage trial data.
from FOX News https://ift.tt/3yf1Npm
from FOX News https://ift.tt/3yf1Npm
Related Posts:
FOX NEWS: Americans’ mental health at new low amid pandemic: poll- FOX NEWS: Coronavirus crippling emergency response agencies: ‘What if you call EMS and nobody comes?’
- FOX NEWS: California mayor lashes out against state’s regional stay-at-home orders
- FOX NEWS: CT bar owner on using personal savings to stay in business
- FOX NEWS: Dr. Nicole Saphier gives timeline for U.S. vaccine rollout
0 comments:
Post a Comment